Best Chemotherapy for testicular cancer doctors in Istanbul: TOP 19 doctors

Specializes in testicular cancer chemotherapy with fellowship training at Hacettepe University Cancer Institute – one of Turkey's leading oncology centers.

• Completed residency at İstanbul Şişli Etfal Teaching and Research Hospital
• Additional training at The University of Texas MD Anderson Cancer Center
• Treats various cancers including breast, ovarian, and gastrointestinal
• Currently practices at Hisar Hospital Intercontinental

Dr. Tanrikulu specializes in chemotherapy for testicular cancer at Anadolu Medical Center – one of Turkey's leading oncology centers.

• Board-certified in medical oncology with 21 years of experience of specialized practice
• Ranked 3rd in Turkey in minor specialty exam
• Led medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Participated in multiple international clinical studies

Prof. Sezer Sağlam specializes in medical oncology at Gayrettepe Florence Nightingale Hospital, focusing on complex cancer cases.

• Over 27 years of experience of experience in medical oncology
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Former attending physician in gastrointestinal oncology

Abdullah Sakin brings extensive academic and clinical expertise to Medipol Bahçelievler Hospital, specializing in medical oncology.

• Former Head of Medical Oncology at Yüzüncü Yıl University
• Sub-specialized at İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi
• Years of experience treating complex oncology cases

Dr. Sinan Karaaslan — Medical Oncologist at Anadolu Medical Center (since 2014). He treats breast, colorectal, and genitourinary cancers; in medical oncology since 2003. Member of the Turkish Medical Association, the Turkish Society of Medical Oncology, and the Turkish Lung Cancer Society.

Why patients choose and trust Dr. Karaaslan:

• Manages complex cases of breast, colorectal, and genitourinary cancers — applies modern systemic therapy tailored to the tumor type and stage.
• Member of the Turkish Medical Association, the Turkish Society of Medical Oncology, and the Turkish Lung Cancer Society.
• Author of numerous peer-reviewed articles and patient education materials on chemo- and immunotherapy.
• Practices at a center with ESMO Designated Centre status and JCI accreditation, within a strategic collaboration with Johns Hopkins Medicine International — one of the leading U.S. medical institutions. For patients, this means care aligned with U.S. protocols and the use of advanced equipment.

Prof. Yeşim (Yesim) Yıldırım — Medical Oncologist at Anadolu Medical Center (since 2011). ESMO-certified specialist, Professor since 2021, author of 80+ scientific publications. Trained at top centers — Rambam (Israel) and Mount Vernon (UK). Treats breast, lung, and gastrointestinal (GI) cancers, as well as melanoma and sarcomas; uses immunotherapy and targeted therapy.

Why patients choose Dr. Yeşim Yıldırım:

• 20+ years of clinical practice; Professor of Medical Oncology since 2021.
• 80+ peer-reviewed publications in tumor biology, immunotherapy, and targeted therapy — treatment plans are based on up-to-date evidence.
• ESMO certification — from Europe’s leading oncology society — confirms high qualification and continuous training to international standards.

Prof. Şeref Kömürcü is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience. He specializes in solid cancer, breast cancer, colorectal and lung cancer treatment and has held teaching and scientific positions throughout his career. He is a member of several professional organizations.

Professor of Medical Oncology with 29 years of experience of experience – Dr. Saglam specializes in gastrointestinal and testicular cancers at Florence Nightingale Hospital.

• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and European Neuroendocrine Tumour Society
• Attending physician in Gastrointestinal Oncology since 2005
• Works at one of Turkey's leading cancer centers

Associate Professor Tahsin Ozatli specializes in treating breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple oncology clinics
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Professor Cemil Bilir specializes in chemotherapy for testicular cancer at VM Medical Park Pendik Hospital, with a strong focus on evidence-based treatment protocols.

• Over 21 years of experience of experience in medical oncology
• Trained in Medical Oncology at Bülent Ecevit University
• Holds memberships in ASCO and ESMO
• Lectured at Sakarya University's Faculty of Medicine

Dr. Ozden brings over 27 years of experience of experience in internal medicine and oncology, specializing in chemotherapy for testicular cancer at VM Medical Park Pendik Hospital.

• Trained at Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Extensive experience across multiple hospitals in Turkey
• Focused practice in medical oncology since 2016

Assoc. Prof. Atakan Topcu specializes in solid tumors, including testicular cancer, with a focus on targeted therapies and immunotherapy at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology
• Member of European Society for Medical Oncology (ESMO)
• Expertise in cancer-related malnutrition and geriatric oncology
• Medical Oncology fellowship from Bezmialem Vakıf University

Professor Cicin specializes in medical oncology with over 29 years of experience of experience, currently at Trakya University Faculty of Medicine.

• Fellowship-trained in medical oncology at Trakya University
• Associate Professor and later Professor at Trakya University
• Military service as a physician in the Turkish Air Force
• Extensive experience in internal medicine before specializing in oncology

Assoc. Prof. Nail Paksoy specializes in testicular cancer chemotherapy at Medipol Bahçelievler Hospital, with a focus on advanced treatment protocols.

• ESMO Board Certified in Medical Oncology
• Participated in 8+ international clinical trials for various cancers
• Published research on high-dose chemotherapy and novel treatment approaches
• Fellowship-trained at Istanbul University Oncology Institute

Associate Professor Muhammed Mustafa Atci specializes in testicular cancer chemotherapy at İstinye University Liv Hospital Topkapı, combining clinical expertise with academic leadership.

• Published research on biomarkers for testicular cancer metastasis
• Member of the American Society of Clinical Oncology (ASCO)
• Education Coordinator for Medical Oncology training programs
• Over 15 years of experience of focused oncology practice

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Specializes in uro-oncology and laparoscopic surgery with extensive experience in treating testicular cancer at Medicana Bahcelievler Hospital.

• Professor of Medicine at Medicana Hospital Bahcelievler
• Trained in urology at Istanbul University School of Medicine
• Expert in laparoscopic and microsurgical techniques
• Focuses on minimally invasive treatments for urological cancers